Patents by Inventor James L. Browning

James L. Browning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10564159
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: February 18, 2020
    Assignee: Diagnostic Hybrids, Inc.
    Inventors: Leonard Kohn, James L. Brown, David R. Scholl, Yunsheng Li, Giorgio Napolitano
  • Patent number: 10088481
    Abstract: The present invention describes a liquid direct fluorescence antibody assay that is rapid and sensitive to detect respiratory virus in infected cells. The assay includes centrifugation of the specimen, incubation of sample and reagents in solution, and detection of the absence or presence of respiratory virus. Sapogenin is used as a detergent to permeabilize the cells for entry of the monoclonal antibodies to react with intracellular antigens. The cells are stained with fluorescently labeled monoclonal antibodies against the viral antigens along with a background stain and a fluorescent nuclear stain. This counter staining decreases background and allows co-localization of antigen and nuclear structures for enhanced detection.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: October 2, 2018
    Assignee: Diagnostic Hybrids, Inc.
    Inventors: David R. Scholl, James L. Brown, Joseph A. Jollick, Jr., Ronald Lollar
  • Patent number: 10041943
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: August 7, 2018
    Assignee: Diagnostic Hybrids, Inc.
    Inventor: James L Brown
  • Publication number: 20180100855
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays. Such improvements are based upon the superior performance of assays comprising a chimeric TSH receptor in the presence of a glucocorticoid including, but not limited to, dexamethasone.
    Type: Application
    Filed: September 26, 2017
    Publication date: April 12, 2018
    Inventors: Leonard Kohn, James L. Brown, David R. Scholl, Yunsheng Li, Giorgio Napolitano
  • Publication number: 20180052159
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Application
    Filed: August 21, 2017
    Publication date: February 22, 2018
    Inventor: James L. Brown
  • Patent number: 9739775
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: August 22, 2017
    Assignee: Diagnostic Hybrids, Inc.
    Inventor: James L. Brown
  • Publication number: 20150301042
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Application
    Filed: December 1, 2014
    Publication date: October 22, 2015
    Inventor: James L. Brown
  • Publication number: 20150192584
    Abstract: The present invention describes a liquid direct fluorescence antibody assay that is rapid and sensitive to detect respiratory virus in infected cells. The assay includes centrifugation of the specimen, incubation of sample and reagents in solution, and detection of the absence or presence of respiratory virus. Sapogenin is used as a detergent to permeabilize the cells for entry of the monoclonal antibodies to react with intracellular antigens. The cells are stained with fluorescently labeled monoclonal antibodies against the viral antigens along with a background stain and a fluorescent nuclear stain. This counter staining decreases background and allows co-localization of antigen and nuclear structures for enhanced detection.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 9, 2015
    Inventors: David R. Scholl, James L. Brown, Joseph A. Jollick, JR., Ronald Lollar
  • Patent number: 8975016
    Abstract: The present invention describes a liquid direct fluorescence antibody assay that is rapid and sensitive to detect respiratory virus in infected cells. The assay includes centrifugation of the specimen, incubation of sample and reagents in solution, and detection of the absence or presence of respiratory virus. Sapogenin is used as a detergent to permeabilize the cells for entry of the monoclonal antibodies to react with intracellular antigens. The cells are stained with fluorescently labeled monoclonal antibodies against the viral antigens along with a background stain and a fluorescent nuclear stain. This counter staining decreases background and allows co-localization of antigen and nuclear structures for enhanced detection.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: March 10, 2015
    Assignee: Diagnostic Hybrids, Inc.
    Inventors: David R. Scholl, James L. Brown, Joseph A. Jollick, Jr., Ronald Lollar
  • Patent number: 8926981
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Grant
    Filed: September 12, 2012
    Date of Patent: January 6, 2015
    Assignee: Diagnostic Hybrids, Inc.
    Inventor: James L. Brown
  • Patent number: 8725470
    Abstract: A method and associated system for multi-disciplinary optimization of various parameters associated with a space vehicle that experiences aerocapture and atmospheric entry in a specified atmosphere. In one embodiment, simultaneous maximization of a ratio of landed payload to vehicle atmospheric entry mass, maximization of fluid flow distance before flow separation from vehicle, and minimization of heat transfer to the vehicle are performed with respect to vehicle surface geometric parameters, and aerostructure and aerothermal vehicle response for the vehicle moving along a specified trajectory. A Pareto Optimal set of superior performance parameters is identified.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: May 13, 2014
    Assignee: The United States of America as Represented by the Administrator of the National Aeronautics & Space Administration (NASA)
    Inventors: James L. Brown, Joseph A Garcia, David J. Kinney, Jeffrey V Bowles, Nagi N Mansour
  • Patent number: 8639948
    Abstract: The subject matter herein relates to database management systems and, more particularly, encrypted data management in database management systems. Various embodiments provide systems, methods, and software to maintain database tables, some of which are encrypted. Some embodiments include holding clear text in cache and servicing queries from the cache. When a query is received, a file system of the database management system determines if a table holding data to service the query is encrypted. If the table is encrypted, the file system decrypts the data and writes the data to the cache as clear text. Some embodiments, when writing clear text to a table from the cache, determine if the table to which the data is to be written is an encrypted table. If the table is encrypted, the file system encrypts the clear text and stores the cipher text to the encrypted table.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: January 28, 2014
    Assignee: Teradata US, Inc.
    Inventor: James L. Browning
  • Publication number: 20130167328
    Abstract: A device(10) which protects an object such as a pair of eyeglasses (G) from being damaged by accidentally or inadvertently falling out a person's shirt pocket (S) or pants' pocket (P). The device comprises a first clip (12) which grips a portion of the eyeglass' frame such as the sidepiece (E) that fits over an ear. The device further includes a second clip (14) which clips onto the cloth of the pocket. Since the eyeglasses are now clipped to a pocket, they are not, and cannot be, readily dislodged and so will not fall out of the pocket when a person leans or bends over.
    Type: Application
    Filed: December 28, 2011
    Publication date: July 4, 2013
    Inventor: James L. Brown
  • Publication number: 20130059312
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Application
    Filed: September 12, 2012
    Publication date: March 7, 2013
    Inventor: James L. Brown
  • Patent number: 8293879
    Abstract: The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.
    Type: Grant
    Filed: October 1, 2007
    Date of Patent: October 23, 2012
    Assignee: Diagnostic Hybrids, Inc.
    Inventor: James L. Brown
  • Patent number: 8280873
    Abstract: The present invention relates to a system for capturing a business context of a user's interaction with a website. The system has a web server containing web pages and a web log. A web log filter extracts data from the web log associated with the address associated with the business context. A data analysis creation tool is in communication with a shared configuration table in the enterprise data warehouse, wherein the data analysis creation tool has executable instructions for creating a logical data model for mapping the extracted data to the enterprise data warehouse. A method for the same is also provided.
    Type: Grant
    Filed: April 17, 2002
    Date of Patent: October 2, 2012
    Assignee: Teradata US, Inc.
    Inventors: Thomas G. Brewer, James L. Browning
  • Publication number: 20120003627
    Abstract: The present invention describes a device for performing a liquid direct fluorescence antibody assay that is rapid and sensitive to detect respiratory virus in infected cells. The device also includes a compatible slide comprising sample wells. The device detects emitted fluorescence signal through a camera and optics assembly that is controlled by a user interface assembly.
    Type: Application
    Filed: June 23, 2011
    Publication date: January 5, 2012
    Inventors: David R. Scholl, James L. Brown, Joseph A. Jollick, JR., Ronald H. Lollar, Brooke B. McCutchan
  • Publication number: 20110269117
    Abstract: The present invention describes a liquid direct fluorescence antibody assay that is rapid and sensitive to detect respiratory virus in infected cells. The assay includes centrifugation of the specimen, incubation of sample and reagents in solution, and detection of the absence or presence of respiratory virus. Sapogenin is used as a detergent to permeabilize the cells for entry of the monoclonal antibodies to react with intracellular antigens. The cells are stained with fluorescently labeled monoclonal antibodies against the viral antigens along with a background stain and a fluorescent nuclear stain. This counter staining decreases background and allows co-localization of antigen and nuclear structures for enhanced detection.
    Type: Application
    Filed: June 22, 2011
    Publication date: November 3, 2011
    Inventors: David R. Scholl, James L. Brown, Joseph A. Jollick, JR., Ronald Lollar
  • Patent number: 8003314
    Abstract: The present invention describes a liquid direct fluorescence antibody assay that is rapid and sensitive to detect respiratory virus in infected cells. The assay includes centrifugation of the specimen, incubation of sample and reagents in solution, and detection of the absence or presence of respiratory virus. Sapogenin is used as a detergent to permeabilize the cells for entry of the monoclonal antibodies to react with intracellular antigens. The cells are stained with fluorescently labeled monoclonal antibodies against the viral antigens along with a background stain and a fluorescent nuclear stain. This counter staining decreases background and allows co-localization of antigen and nuclear structures for enhanced detection.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: August 23, 2011
    Assignee: Diagnostic Hybrids, Inc.
    Inventors: David R. Scholl, James L. Brown, Joseph A. Jollick, Jr., Ronald Lollar
  • Patent number: 7818206
    Abstract: A system and method profiles different users having a common terminal identifier in communication system. The system comprises a user activity data analyzer for extracting profile data from user terminal activity data, a user identifier for determining whether the profile data corresponds to a profile data history associated with the user terminal, and a user profile generator for generating a profile data history from the profile data for another user to be associated with the terminal in response to the profile data not corresponding to the profile data history associated with the user terminal. The user activity data analyzer extracts site addresses, URLs, click event data, metadata and other user activity from a session log to compile information useful for assessing a user's interests. This extracted profile data may then be compared to a profile history previously generated and associated with the terminal identifier.
    Type: Grant
    Filed: October 29, 2001
    Date of Patent: October 19, 2010
    Assignee: Teradata US, Inc.
    Inventors: Tucker L. Smith, James L. Browning